International Patent: METHODS OF TREATMENT AND PREVENTION OF POST-SURGICAL THROMBOSIS OR DISORDERS USING FACTOR XI (FXI) BINDING ANTIBODIES

GENEVA, July 2 -- REGENERON PHARMACEUTICALS, INC. filed a patent application (US2025/060035) for “METHODS OF TREATMENT AND PREVENTION OF POST-SURGICAL THROMBOSIS OR DISORDERS USING FACTOR XI (FXI) BINDING ANTIBODIES”. With publication no. WO/2026/136494, here are the other details related to the patent application:

Kind: Initial Publication without ISR [A2]

IPC: none

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....